Abstract
P16INK4a (CDKN2A) is a central tumor-suppressor and activator of senescence. We recently found that prolonged expression of p16INK4a in epidermal cells induces hyperplasia and dysplasia through Wnt-mediated stimulation of neighboring keratinocytes. The study suggests a pro-tumorigenic function of p16INK4a in early epidermal lesions, which could potentially be targeted by senolytic therapy.
Funding Information
  • Israel Science Foundation (1009/13, 2092/18)
  • DKFZ-MOST ((CA-161) (I.B.))
  • Israel Council for Higher Education (N.A.)

This publication has 10 references indexed in Scilit: